CAR T across hematological malignancies: trials to watch
Understanding how genetic mutations affect outcome in CLL
Are CAR NK-cells the future of CLL therapy?
CAR T-cells in CLL: the current landscape
MRD Focus: why measurable residual disease testing is the future
Bruno Paiva et al.